Explore › Outcome › Neurodevelopmental impairment
Outcome

Neurodevelopmental impairment

Also known as: Neurodevelopmental impairment at 18-22 months corrected age
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
History of gastrostomy tube placement1
conditions
Premature baby oral feeding plate1
populations
Children1
studys
PMC68157001

Findings (27)

None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →
None
decline

Gastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy

Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10

Size: OR 3.19 CI: 95% CI 2.49-4.10
PMC6815700
Finding details → · Paper → · Graph →

Papers (1)